Current Treatment Options in Neurology

, Volume 12, Issue 1, pp 16–28

Myotonia Congenita and Myotonic Dystrophy: Surveillance and Management

Neuromuscular Disorders

DOI: 10.1007/s11940-009-0055-z

Cite this article as:
Conravey, A. & Santana-Gould, L. Curr Treat Options Neurol (2010) 12: 16. doi:10.1007/s11940-009-0055-z

Opinion statement

Myotonia can be treated both pharmacologically and by lifestyle modifications. Cell membrane stabilizers are the medications most commonly used for symptomatic treatment of myotonia. Most patients do not require treatment for the myotonia itself, unless it is severe, but physicians must be aware of anesthesia risks in both myotonia congenita and myotonic dystrophy. A mainstay of management of myotonic dystrophy is the surveillance and treatment of its various systemic complications.

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.Department of PediatricsTulane UniversityNew OrleansUSA